HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pregnancy termination using vaginal misoprostol in women with more than one caesarean section.

Abstract
We set out to evaluate the safety and efficacy of the proposed misoprostol regimen in women with previous multiple caesarean sections. This was a retrospective cohort study of 21 women with more than one caesarean section who underwent termination of pregnancy (TOP) with 400 mug of vaginal misoprostol followed by 200 mug/6 h (max 800 mug). The complete abortion rate was 12/21 (57.14%) and six (28.57%) women had an incomplete abortion. Three TOPs (14.29%) failed. In the first trimester group, only 3/9 (33.34%) aborted completely, while (9/12) 75% second trimester patients aborted completely. There were no major complications. The proposed regimen is considered safe and reasonably effective in second trimester TOPs in women with previous multiple caesarean sections. In first trimester patients, the possibility of manual vacuum aspiration (MVA) should be discussed during counselling, or a higher dose should be used as the effectiveness is low.
AuthorsA Daponte, G Nzewenga, K D Dimopoulos, F Guidozzi
JournalJournal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology (J Obstet Gynaecol) Vol. 27 Issue 6 Pg. 597-600 (Aug 2007) ISSN: 0144-3615 [Print] England
PMID17896259 (Publication Type: Journal Article)
Chemical References
  • Abortifacient Agents, Nonsteroidal
  • Misoprostol
Topics
  • Abortifacient Agents, Nonsteroidal (administration & dosage)
  • Abortion, Induced (methods)
  • Administration, Intravaginal
  • Adult
  • Cesarean Section, Repeat
  • Cohort Studies
  • Female
  • Humans
  • Misoprostol (administration & dosage)
  • Pregnancy
  • Pregnancy Trimester, First
  • Pregnancy Trimester, Second
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: